Europe Hyaluronic Acid Based Dermal Fillers Market Analysis Report By Product (Single-phase, Duplex), By Application (Wrinkle Removal, Lip Augmentation), And Segment Forecasts, 2019 - 2026

Published: May, 2019 | Pages: 102 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The Europe hyaluronic acid based dermal fillers market size is expected to reach USD 2.1 billion by 2026, according to a new report by Grand View Research Inc., exhibiting a CAGR of 11.6% over the forecast period. Rapidly aging population, large number of cosmetic surgeries performed, and technological advancements are among key factors driving the market. Growing demand to enhance one's aesthetic appeal is resulting in high number of cosmetic surgeries being performed. This can also be attributed to the availability of noninvasive surgical alternatives and rising awareness among consumers. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2017, hyaluronic acid-based dermal filler procedures were among the three most preferred noninvasive aesthetic surgeries.

Minimal adverse effects, lesser pain, shorter recovery time, and fewer postsurgical complications are some of the factors driving preference for minimally invasive surgeries. The European market is dominated by well-known brands such as Juvederm, Restylane, and Belotero. In addition, France has several native brands with different patented technologies, thereby contributing to regional market growth. Stylage, Cytosial, Hyaluronica, and Surface Volume are some of the local brands available in the market.

Increasing demand for aesthetic procedures majorly in Italy and Spain is creating a great opportunity for market expansion. According to the ISAPS, about 952,830 aesthetic surgeries were performed in 2016, of which 650,995 were noninvasive procedures such as Botox and dermal fillers.

Various strategic initiatives such as product launch, approvals, and mergers and acquisitions propel the market. For instance, in January 2017, Allergan plc launched Juvederm VOLITE, a new hyaluronic acid dermal filler with its unique patented VYCROSS technology, which lasts for up to nine months. In another instance, in September 2018, Allergan acquired Bonti, Inc. to expand its product portfolio with Bonti's pipeline products such as (BoNT/E) botulinum neurotoxin serotype E in phase II, EB-001T (therapeutic), and EB-001A (aesthetic).

Further key findings from the report suggest:

• Increase in per capita income in countries such as Germany, Italy, France, and Spain is a key factor driving the adoption of dermal fillers. Rapid advancements in dermal filler technology have resulted in better results in lesser time and at lower costs

• In 2018, single-phase products dominated the market owing to technological advancements, wide range of applications, and rise in applications of implantable devices

• By application, the wrinkle removal segment is anticipated to grow at the fastest rate during the forecast period. Hyaluronic acid dermal fillers are gaining popularity in varied antiaging treatments as they help save time. A general hyaluronic acid anti-wrinkle treatment procedure takes less than an hour and the average cost is approximately USD 600

• Italy dominated the regional market in 2018 owing to technological advancements in the region and introduction of new products by prominent manufacturers

• Some of the key players in this industry are Allergan; Galderma Laboratories; Merz Pharma; Genzyme Corporation; Medicis Pharmaceutical; Inamed Corporation; Anika Therapeutics, Inc.; Laboratoires VIVACY; Bioxis Pharmaceuticals; and Bohus Biotech AB.

 Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Market Segmentation & Scope
                     1.1.1 Product
                     1.1.2 Application
                     1.1.3 Country
                     1.1.4 Estimates and Forecast Timeline
                 1.2 Research Methodology
                 1.3 Information Procurement
                     1.3.1 Purchased database
                     1.3.2 GVR's Internal Database
                     1.3.3 Secondary Sources
                     1.3.4 Primary Research
                 1.4 Information or Data Analysis
                 1.5 Market Formulation & Validation
                 1.6 Model Details
                     1.6.1 Commodity Flow Analysis
                     1.6.2 Volume Price Analysis
                 1.7 List of Secondary Sources
                 1.8 List of Primary Sources
                 1.9 List of Abbreviations
                 1.10 Objectives
                     1.10.1 Objective - 1
                     1.10.2 Objective - 2

Chapter 2 Executive Summary
                 2.1 Market Outlook
                 2.2 Segment Outlook
                     2.2.1 Product
                     2.2.2 Application
                     2.2.3 Country
                 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
                 3.1 Market Lineage outlook
                     3.1.1 Parent Market Outlook
                     3.1.2 Related/Ancillary Market Outlook
                 3.2 Market Segmentation
                 3.3 User Perspective Analysis
                     3.3.1 Consumer Behavior Analysis
                     3.3.2 Market Influencer Analysis
                 3.4 Market Dynamics
                     3.4.1 Market Driver Analysis
                         3.4.1.1 Growing demand for anti-aging solutions and minimally invasive aesthetic treatments
                         3.4.1.2 Growing applications in regenerative medicine and tissue engineering
                     3.4.2 Market Restraint Analysis
                         3.4.2.1 High cost and adverse effects associated with hyaluronic acid cycles
                     3.4.3 Market Opportunity Analysis
                         3.4.3.1 Rising demand for aesthetic procedures in emerging markets
                 3.5 Penetration & Growth Prospect Mapping
                     3.5.1 Analysis
                 3.6 Business Environment Analysis Tools
                     3.6.1 Porter's Five Forces Analysis
                     3.6.2 PESTEL Analysis
                 3.7 Regulatory Framework & Reimbursement Scenario
                 3.8 Clinical Trials
                 3.9 List of Key End-users
                 3.10 Major Deals & Strategic Alliances Analysis
                     3.10.1 Product Launch
                     3.10.2 Mergers & Acquisitions
                     3.10.3 Partnerships

Chapter 4 Europe Hyaluronic Acid-Based Dermal Fillers Market: Product Analysis
                 4.1 Europe Hyaluronic Acid-Based Dermal Fillers Product Market Share Analysis, 2018 & 2026
                 4.2 Europe Hyaluronic Acid-Based Dermal Fillers Product Market: Segment Dashboard
                 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
                     4.3.1 Single-Phase Productss
                         4.3.1.1 Single-Phase Productss market, 2015 - 2026 (USD Million)
                     4.3.2 Duplex Products
                         4.3.2.1 Duplex products market, 2015 - 2026 (USD Million)

Chapter 5 Europe Hyaluronic Acid-Based Dermal Fillers Market: Application Analysis
                 5.1 Europe Hyaluronic Acid-Based Dermal Fillers Application Market Share Analysis, 2018 & 2026
                 5.2 Europe Hyaluronic Acid Based Dermal Fillers Application Market: Segment Dashboard
                 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application
                     5.3.1 Wrinkle Removal
                         5.3.1.1 Wrinkle removal market, 2015 - 2026 (USD Million)
                     5.3.2 Lip Augmentation
                         5.3.2.1 Lip augmentation market, 2015 - 2026 (USD Million)
                     5.3.3 Rhinoplasty
                         5.3.3.1 Rhinoplasty market, 2015 - 2026 (USD Million)
                     5.3.4 Others
                         5.3.4.1 Others market, 2015 - 2026 (USD Million)

Chapter 6 Europe Hyaluronic Acid Based Dermal Fillers Market: Country Analysis
                 6.1 Europe Hyaluronic Acid Based Dermal Fillers Country Market Share Analysis, 2018 & 2026
                 6.2 Europe Hyaluronic Acid Based Dermal Fillers Country Market: Segment Dashboard
                 6.3 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
                     6.3.1 Europe
                         6.3.1.1 Europe hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
                     6.3.2 U.K.
                         6.3.2.1 Regulations
                         6.3.2.2 U.K. hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
                     6.3.3 Germany
                         6.3.3.1 Regulations
                         6.3.3.2 Germany hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
                     6.3.4 France
                         6.3.4.1 Regulations
                         6.3.4.2 France hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
                     6.3.5 Italy
                         6.3.5.1 Regulations
                         6.3.5.2 Italy hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
                     6.3.6 Spain
                         6.3.6.1 Regulations
                         6.3.6.2 Spain hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)

Chapter 7 Competitive Analysis
                 7.1 Recent developments & impact analysis, by key market participants
                 7.2 Strategic Framework/ Competition Categorization (Key innovators, market leaders, emerging players)
                 7.3 Vendor Landscape
                     7.3.1 List of Key Distributors And Channel Partners
                     7.3.2 Key Customers
                     7.3.3 Strategy Mapping
                 7.4 Public Companies
                     7.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, strategic initiatives, employee strength)
                 7.5 Private Companies
                     7.5.1 Company market position analysis (Geographic presence, product portfolio, strategic initiatives, employee strength)
                 7.6 Company Profiles
                     7.6.1 Allergan
                         7.6.1.1 Company overview
                         7.6.1.2 Financial performance
                         7.6.1.3 Product benchmarking
                         7.6.1.4 Strategic initiatives
                         7.6.1.5 SWOT analysis
                     7.6.2 Galderma Laboratories
                         7.6.2.1 Company overview
                         7.6.2.2 Financial performance
                         7.6.2.3 Product benchmarking
                         7.6.2.4 Strategic initiatives
                         7.6.2.5 SWOT analysis
                     7.6.3 Merz Pharma
                         7.6.3.1 Company overview
                         7.6.3.2 Product benchmarking
                         7.6.3.3 Strategic initiatives
                     7.6.4 Genzyme corporation
                         7.6.4.1 Company overview
                         7.6.4.2 Financial performance
                         7.6.4.3 Product benchmarking
                         7.6.4.4 SWOT analysis
                     7.6.5 Medicis Pharmaceutical (Bausch Health)
                         7.6.5.1 Company overview
                         7.6.5.2 Financial performance
                         7.6.5.3 Product benchmarking
                         7.6.5.4 Strategic initiatives
                         7.6.5.5 SWOT analysis
                     7.6.6 Inamed Corporation
                         7.6.6.1 Company overview
                         7.6.6.2 Product benchmarking
                     7.6.7 Anika Therapeutics, Inc.
                         7.6.7.1 Company overview
                         7.6.7.2 Financial performance
                         7.6.7.3 Product benchmarking
                         7.6.7.4 Strategic initiatives
                         7.6.7.5 SWOT analysis
                     7.6.8 Laboratoires VIVACY
                         7.6.8.1 Company overview
                         7.6.8.2 Product benchmarking
                         7.6.8.3 Strategic initiatives
                     7.6.9 Bioxis Pharmaceuticals
                         7.6.9.1 Company overview
                         7.6.9.2 Product benchmarking
                         7.6.9.3 Strategic initiatives
                     7.6.10 Bohus Biotech AB
                         7.6.10.1 Company overview
                         7.6.10.2 Product benchmarking

Chapter 8 Recommendations
                 8.1 Key Insights

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviation
TABLE 3 Europe Hyaluronic Acid Based Dermal Fillers Market, by Country, 2015 - 2026 (USD Million)
TABLE 4 Europe Hyaluronic Acid Based Dermal Fillers Market, by Product, 2015 - 2026 (USD Million)
TABLE 5 Europe Hyaluronic Acid Based Dermal Fillers Market, by Application, 2015 - 2026 (USD Million)
TABLE 6 List of Few Players at Country Level
TABLE 7 U.K. Hyaluronic Acid Based Dermal Fillers Market, by Product, 2015 - 2026 (USD Million)
TABLE 8 U.K. Hyaluronic Acid Based Dermal Fillers Market, by Application, 2015 - 2026 (USD Million)
TABLE 9 Germany Hyaluronic Acid Based Dermal Fillers Market, by Product, 2015 - 2026 (USD Million)
TABLE 10 Germany Hyaluronic Acid Based Dermal Fillers Market, by Application, 2015 - 2026 (USD Million)
TABLE 11 France Hyaluronic Acid Based Dermal Fillers Market, by Product, 2015 - 2026 (USD Million)
TABLE 12 France Hyaluronic Acid Based Dermal Fillers Market, by Application, 2015 - 2026 (USD Million)
TABLE 13 Italy Hyaluronic Acid Based Dermal Fillers Market, by Product, 2015 - 2026 (USD Million)
TABLE 14 Italy Hyaluronic Acid Based Dermal Fillers Market, by Application, 2015 - 2026 (USD Million)
TABLE 15 Spain Hyaluronic Acid Based Dermal Fillers Market, by Product, 2015 - 2026 (USD Million)
TABLE 16 Spain Hyaluronic Acid Based Dermal Fillers Market, by Application, 2015 - 2026 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market outlook
FIG. 9 Europe hyaluronic acid based dermal fillers market segmentation
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Market opportunity relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping
FIG. 15 Porter's five forces analysis
FIG. 16 PESTEL analysis
FIG. 17 Europe hyaluronic acid-based dermal fillers product market share analysis, 2018 & 2026
FIG. 18 Europe hyaluronic acid-based dermal fillers product market: Segment dashboard
FIG. 19 Single-Phase Products market, 2015 - 2026 (USD Million)
FIG. 20 Duplex products market, 2015 - 2026 (USD Million)
FIG. 21 Europe hyaluronic acid-based dermal fillers application market share analysis, 2018 & 2026
FIG. 22 Europe hyaluronic acid-based dermal fillers application market: Segment dashboard
FIG. 23 Wrinkle removal market, 2015 - 2026 (USD Million)
FIG. 24 Lip augmentation market, 2015 - 2026 (USD Million)
FIG. 25 Rhinoplasty market, 2015 - 2026 (USD Million)
FIG. 26 Others market, 2015 - 2026 (USD Million)
FIG. 27 Europe hyaluronic acid based dermal fillers regional market share analysis, 2018 & 2026
FIG. 28 Europe hyaluronic acid based dermal fillers regional market: Segment dashboard
FIG. 29 Europe hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 30 U.K. hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 31 Germany hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 32 France Europe hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 33 Italy hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 34 Spain Europe hyaluronic acid based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 35 Strategy framework
FIG. 36 Strategy framework
FIG. 37 Strategy mapping
FIG. 38 Company market position analysis (Revenue, geographic presence, product portfolio, strategic initiatives, employee strength)
FIG. 39 Company market position analysis (Revenue, geographic presence, product portfolio, strategic initiatives, employee strength)